Development of a ^99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model

Publication: PLoS ONE
UBC Author(s): Urs Hafeli (Faculty of Pharmaceutical Sciences / Faculty of Pharmaceutical Sciences)
Volume: 19
Publication Date: April 2024